Source: (2020)
LGI1 (leucine-rich glioma inactivated 1) antibodies are associated with autoimmune limbic encephalitis and seizures. Key findings include:
Binding Specificities: Patient-derived monoclonal antibodies (mAbs) target either the LRR (leucine-rich repeat) or EPTP (epitempin repeat) domains of LGI1.
Pathogenic Mechanisms:
LRR-specific mAbs:
Bind tightly to LGI1-ADAM22/23 complexes, inducing internalization in neurons.
Disrupt synaptic function by downregulating AMPA receptors and Kv1.1 channels.
EPTP-specific mAbs:
Inhibit LGI1-ADAM22/23 interactions but show weaker binding to rodent brain sections.
| Antibody Type | Binding Domain | Brain Binding | Functional Impact |
|---|---|---|---|
| LRR-specific | LRR | Strong | Synaptic disruption |
| EPTP-specific | EPTP | Weak | Inhibits interactions |
Clinical Relevance: IgG4 subclass dominates in patient sera, suggesting chronic immune activation .
Source: (2004)
Lub1 is a conserved protein in Schizosaccharomyces pombe regulating ubiquitin homeostasis. Key functions:
Ubiquitin Stabilization: Prevents excessive degradation of ubiquitin via negative regulation.
Stress Response: Interacts with Cdc48 (a chaperon-like ATPase) to maintain cellular stress resilience.
| Phenotypic Defects in lub1 Mutants | Observed Effects |
|---|---|
| Ubiquitin depletion | Hypersensitivity to heat/UV |
| Protein degradation defects | Accelerated ubiquitin turnover |
| Cellular morphology | Enlarged, round cells |
Mechanistic Insight: Overexpression of ubiquitin genes rescues mutant phenotypes, confirming Lub1’s role in post-transcriptional ubiquitin regulation .
Sources: , , (2019–2023)
The Lutheran system involves two primary antigens (Lua and Lub) on red cell glycoproteins (Lu/BCAM). Key characteristics:
Antibody Types:
Anti-Lua: Most common; IgM predominant, with IgG/IgA components.
Anti-Lub: Less frequent; often associated with other antibodies.
Clinical Impact:
| Blood Group Phenotype | Antigen Expression | Antibody Reactivity |
|---|---|---|
| Lu(a-b+) | Lua dominant | Anti-Lua |
| Lu(a-b-) | Null phenotype | Anti-Lu3 (broad reactivity) |
Immunoblotting Data: Anti-Lub monoclonal antibodies (e.g., clone 1E3) identify 85–78 kDa glycoproteins dependent on N-glycosylation and disulfide bonds .
Therapeutic Use: Intra-articular injection for osteoarthritis (OA) treatment.
Pharmacokinetics:
Half-lives: 4.5 h (alpha), 1.5 days (beta), 2.1 weeks (gamma).
Tissue Retention: Detectable on cartilage up to 28 days post-injection.
| Efficacy in Rat OA Model | |
|---|---|
| Cartilage Degradation | Reduced by 50% (vs. vehicle) |
| Pain Scores | Improved by 70% |
KEGG: spo:SPBC887.04c
STRING: 4896.SPBC887.04c.1
Lub1 is a highly conserved 713-amino-acid protein in Schizosaccharomyces pombe (fission yeast) that functions as a homologue of Ufd3p/Zzz4p/Doa1p in budding yeast. It plays a critical role in the posttranscriptional regulation of cellular ubiquitin contents and stress responses .
Specifically, lub1 participates in:
Maintenance of ubiquitin homeostasis at the protein level
Negative regulation of ubiquitin degradation
Ubiquitin/proteasome-dependent proteolysis
Cellular responses to various stress conditions
Disruption of the lub1+ gene results in monoubiquitin and multiubiquitin depletion without changes in mRNA levels, leading to hypersensitivity to various stress conditions including UV irradiation, high temperature, calcium stress, and oxidative stress .
Lub1 contains conserved domains that are critical for its function and can serve as important epitopes for antibody development:
WD domain: Essential for the stability of Lub1, likely through its interaction with Cdc48 . This domain forms a β-propeller structure that could serve as an important antigenic determinant.
N-terminal region (amino acids 1-279): Contains the WD domain and has been specifically studied through truncation experiments .
C-terminal region (amino acids 230-713): Contains functional domains that might serve as potential antibody targets.
When designing antibodies against lub1, these structural features should be considered to ensure optimal recognition of the target protein in its native conformation.
Lub1 antibodies can be valuable tools for studying ubiquitin regulation pathways in lower and potentially higher eukaryotes. Key applications include:
Protein localization studies: Determining the subcellular distribution of lub1 in fission yeast and potentially in mammalian homologues
Protein interaction studies: Investigating interactions between lub1 and its partners, particularly Cdc48
Expression level analysis: Monitoring lub1 protein levels during stress responses and other cellular conditions
Functional studies: Examining the role of lub1 in ubiquitin homeostasis and stress response pathways
Comparative studies: Investigating functional conservation between lub1 and its homologues in other organisms
Lub1 antibodies provide a valuable tool for investigating the molecular mechanisms underlying ubiquitin homeostasis:
Co-immunoprecipitation experiments: These can be designed to identify proteins that interact with lub1 during ubiquitin regulation. Protocol approach:
Lyse cells under non-denaturing conditions
Pre-clear lysates with protein A/G beads
Incubate with lub1 antibody (optimally 2-5 μg per mg of protein)
Precipitate antibody-protein complexes with protein A/G beads
Analyze interacting partners by mass spectrometry or Western blotting
Chromatin immunoprecipitation (ChIP): If lub1 has any role in transcriptional regulation of ubiquitin or related genes, ChIP using lub1 antibodies can map its genomic binding sites.
Immunofluorescence microscopy: To track changes in lub1 localization during stress responses, which could provide insights into its regulatory mechanisms.
Proximity labeling: Using engineered lub1 fusion proteins with proximity labeling enzymes (BioID, APEX) combined with lub1 antibodies for verification to identify transient or weak interactors in the ubiquitin regulation pathway.
The research documented in shows that lub1-deleted cells display hypersensitivity to various stress conditions. Advanced experimental approaches using lub1 antibodies could include:
Temporal proteomic analysis:
Subject cells to different stressors (UV, heat, oxidative agents)
Collect samples at various time points (0, 15, 30, 60, 120 minutes)
Immunoprecipitate lub1 and analyze associated proteins
Monitor changes in lub1 post-translational modifications
Sub-cellular fractionation:
Separate cytoplasmic, nuclear, and membrane fractions
Quantify lub1 distribution across fractions using the antibody
Track re-localization of lub1 under different stress conditions
Proteasome activity assays:
Compare proteasome activity in wild-type versus lub1-depleted cells
Use lub1 antibodies to immunodeplete the protein from extracts
Analyze effects on ubiquitin-dependent proteolysis
Domain-specific lub1 antibodies can be powerful tools for dissecting protein function:
Epitope mapping strategy:
Generate antibodies against WD domain (amino acids 1-279)
Generate antibodies against C-terminal region (amino acids 230-713)
Confirm specificity using recombinant domain fragments
Domain blockade experiments:
Use domain-specific antibodies to potentially block interactions
Compare effects of blocking different domains on lub1 function
Measure impact on ubiquitin levels and stress responses
Conformational studies:
Employ conformation-specific antibodies that recognize lub1 in different states
Monitor conformational changes under stress conditions
Correlate with functional outcomes
Domain-specific antibodies would be especially valuable for investigating the specific roles of the WD domain, which appears critical for lub1 stability through its interaction with Cdc48 .
Developing specific antibodies against lub1 requires careful consideration of several factors:
Antigen design options:
Full-length recombinant lub1 protein
Synthetic peptides from unique, surface-exposed regions
Domain-specific fragments (WD domain or C-terminal region)
Host selection considerations:
Rabbits: Good for polyclonal antibodies with high affinity
Mice/rats: Suitable for monoclonal antibody development
Chickens: Useful for generating antibodies against highly conserved proteins
Validation approach:
Western blot analysis using wild-type and lub1-deleted yeast strains
Immunoprecipitation followed by mass spectrometry
Immunofluorescence comparison between wild-type and mutant cells
Advanced library design:
Recent advances in antibody library design using computational methods as described in can be leveraged to develop highly specific antibodies against lub1. This approach combines:
Deep learning predictions of mutation effects
Integer linear programming optimization
Diversity constraints to ensure broad epitope coverage
A comprehensive validation strategy should include:
Primary validation tests:
Western blotting using lub1-knockout cells as negative controls
Peptide competition assays to confirm epitope specificity
Immunoprecipitation followed by mass spectrometry identification
Secondary validation tests:
Immunofluorescence microscopy comparing wild-type and lub1-deleted cells
Cross-reactivity testing against closely related proteins
Dot blot analysis with purified recombinant lub1 protein
Functional validation:
Antibody microinjection to test for functional interference
Validation in heterologous expression systems
Correlation of signal intensity with known lub1 expression patterns
| Validation Method | Technical Approach | Expected Outcome for Specific Antibody |
|---|---|---|
| Western Blot | Compare wild-type vs. Δlub1 lysates | Single band at 713aa (~78 kDa) in wild-type, absent in Δlub1 |
| Immunoprecipitation | Pull-down from wild-type lysate followed by MS | Identification of lub1 and known interactors (e.g., Cdc48) |
| Peptide Competition | Pre-incubate antibody with immunizing peptide | Signal diminution or elimination |
| Immunofluorescence | Compare staining in wild-type vs. Δlub1 cells | Cytoplasmic and nuclear staining in wild-type, absent in Δlub1 |
Given that lub1 interacts with Cdc48 through its WD domain , co-immunoprecipitation (co-IP) studies are particularly relevant:
Optimal lysis conditions:
Use non-denaturing lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA)
Include protease inhibitors and deubiquitinase inhibitors
Maintain samples at 4°C throughout to preserve protein-protein interactions
Co-IP protocol optimization:
Cross-titrate lub1 and Cdc48 antibodies to determine optimal concentrations
Consider chemical crosslinking (e.g., DSP) for capturing transient interactions
Test both direct IP (anti-lub1) and reverse IP (anti-Cdc48) approaches
Controls and verification:
Include IgG isotype controls
Use Δlub1 and Cdc48 mutant strains as negative controls
Validate with recombinant proteins expressed in heterologous systems
Advanced approaches:
Sequential IP (tandem affinity purification) for higher specificity
Native gel electrophoresis followed by Western blotting
Size exclusion chromatography combined with immunodetection
Distinguishing specific from non-specific signals requires systematic controls:
Essential controls:
Δlub1 lysates as negative controls
Recombinant lub1 as positive controls
Secondary antibody-only controls to identify background signals
Signal validation approaches:
Peptide competition assays (pre-incubate antibody with immunizing peptide)
Use multiple antibodies targeting different lub1 epitopes
Compare signal patterns with orthogonal detection methods
Technical considerations:
Optimize blocking conditions (5% BSA often superior to milk for phospho-specific antibodies)
Test varying antibody dilutions (typically 1:500 to 1:5000 range)
Consider gradient gels for better resolution of the ~78 kDa lub1 protein
Data interpretation guidelines:
Specific lub1 signal should disappear in Δlub1 samples
Signal intensity should correlate with known expression levels
Compare molecular weight with predicted size (approximately 78 kDa for full-length lub1)
Lub1 is evolutionarily conserved, with homologues in other organisms (e.g., Ufd3p/Doa1p in budding yeast and PLAP in humans) . When using lub1 antibodies across species:
Sequence homology analysis:
Perform sequence alignments to identify conserved regions
Generate phylogenetic trees to understand evolutionary relationships
Predict cross-reactivity based on epitope conservation
Cross-reactivity testing protocol:
Test antibodies on lysates from multiple species
Use recombinant proteins from different species as controls
Perform epitope mapping to identify conserved binding regions
Optimization strategies:
Adjust antibody concentrations based on binding affinity differences
Modify blocking and washing conditions for each species
Consider using different secondary antibodies optimized for each host species
Functional conservation considerations:
Compare phenotypes between species to validate functional homology
Use complementation studies to confirm functional equivalence
Design experiments to investigate species-specific differences in lub1 function
The relationship between lub1 and ubiquitin homeostasis can be further explored using antibody-based methods:
Co-localization studies:
Double immunofluorescence with lub1 and proteasome component antibodies
Super-resolution microscopy to examine spatial relationships
Live-cell imaging using fluorescently tagged proteins validated with antibodies
Ubiquitin dynamics analysis:
Immunoprecipitate lub1 and probe for ubiquitinated proteins
Use linkage-specific ubiquitin antibodies (K48, K63) to characterize modified proteins
Perform in vitro ubiquitination assays with recombinant components
Proteasome interaction studies:
Co-immunoprecipitation of lub1 with proteasome subunits
Proteasome activity assays in the presence/absence of lub1
Analyze effects of lub1 antibody addition on proteasome function in vitro
Stress response protocols:
Track changes in lub1-ubiquitin associations during stress responses
Monitor proteasome localization in wild-type versus Δlub1 cells under stress
Quantify ubiquitinated protein levels in response to lub1 manipulation
The conservation of lub1 across species suggests broader applications for lub1 antibodies:
Comparative biology approaches:
Test antibody cross-reactivity with homologues in diverse species
Investigate conservation of lub1-mediated ubiquitin regulation
Compare stress response mechanisms across evolutionary distance
Disease model applications:
Examine the role of human homologues in neurodegenerative diseases
Investigate connections to protein aggregation disorders
Study potential dysregulation in cancer models
Systems biology integration:
Map lub1 interaction networks across species
Identify conserved and divergent regulatory hubs
Develop predictive models of ubiquitin homeostasis
Technological approaches:
Apply CRISPR-based tagging validated with lub1 antibodies
Develop biosensors for monitoring lub1 activity in real-time
Implement antibody-based proteomics to map the "lub1-ome"
Advanced antibody engineering techniques can enhance lub1 antibody functionality:
Emerging antibody formats:
Single-domain antibodies (nanobodies) for improved intracellular delivery
Bispecific antibodies targeting lub1 and interaction partners simultaneously
Recombinant antibody fragments with enhanced tissue penetration
Computational design strategies:
Affinity maturation techniques:
Directed evolution using yeast or phage display
Rational design of complementarity-determining regions
Combinatorial approaches to identify optimal binding variants
Functional enhancement strategies:
Site-specific conjugation for reporter molecule attachment
pH-sensitive variants for endosomal escape
Thermostable derivatives for challenging experimental conditions
Lub1's involvement in stress response pathways opens avenues for broader research:
Integrated stress response investigations:
Map lub1's position in the hierarchy of stress response pathways
Identify potential crosstalk between lub1-mediated and other stress responses
Develop models of cellular resilience incorporating ubiquitin homeostasis
Translational research directions:
Examine cellular protection mechanisms against proteotoxic stress
Investigate potential applications in neurodegenerative disease models
Explore connections to aging and longevity pathways
Experimental approaches:
Develop lub1 reporter systems for monitoring stress in real-time
Create cellular stress models with tunable lub1 expression
Implement high-content screening for modulators of lub1 function
Interdisciplinary applications:
Connect lub1 function to metabolic adaptation during stress
Investigate environmental influences on ubiquitin homeostasis
Develop mathematical models of cellular resilience incorporating lub1 activity